The C-terminal Agrin fragment (CAF) has emerged as a promising biomarker for NMJ degeneration, with higher serum concentrations observed in older adults correlating with decreased muscle strength and sarcopenia (Monti et al., 2023; Pratt et al., 2021). The gene discussed is AGRN; the disease is sarcopenia.